Biotech Stocks

Ready, Aim, Bargain Hunt

Those with a good risk tolerance should use the current weakness to buy high-quality, oversold stocks. More 

VIDEO: Biotechs Fall, Momentum Stocks Break Down and More

Charles Sizemore sits down to talk biotech and momentum stocks with Fox Business' Charles Payne. More 

New Biotech Breakthrough: Buy Intermune Stock

A raft of good news has powered Intermune, and I believe the good news will continue, and Intermune stock is a buy More 

Trade of the Day: Teva Pharmaceuticals (TEVA) and Mylan (MYL)

Recent price shocks in biotech stocks is a good example of the risks investors may be exposed to as healthcare continues to become more complicated. More 

Buy Biotech’s Burst Bubble… Just Not Quite Yet

Delay purchases unless several strong days of selling drive it to its 200-day moving average. More 

4 Ways to Play the Boom in Biotech Stocks

Whether you love risk or hate it, there's a way to invest in red-hot biotech stocks. Here are four options for investors of all different tolerances. More 

Is It Too Late to Buy the Rally in Small Caps?

Small cap stocks have delivered stellar returns in 2014, but the rally may be getting overextended. Is there any opportunity left for small caps? More 

5 Biotech Stocks Promising Future Rewards

Biotech is one of the dynamic sectors in our economy, and in the stock market as well. These 5 biotech stocks are solid buys in our Portfolio Grader model. More 

MYL Earnings Momentum Propels Mylan Stock to a Buy

Biogeneric drugmaker Mylan is undergoing soaring growth based on its backlog of generics waiting for U.S government approval to market. Mylan stock is a buy More 

5 Biotech Stocks That Are Buyout Candidates

These biotech stocks are this year's top M&A candidates. But even if they're not acquired, they're solid biopharma investments. More